Literature DB >> 7850963

Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.

Y Hirata1, H Hayakawa, E Suzuki, K Kimura, K Kikuchi, T Nagano, M Hirobe, M Omata.   

Abstract

BACKGROUND: Stimulation of endothelin subtype B (ETB) receptors has been proposed to induce release of endothelium-derived nitric oxide (EDNO). METHODS AND
RESULTS: To obtain direct evidence of its release and its alteration in deoxycorticosterone acetate (DOCA)-salt hypertension, EDNO released from renal vessels by ET stimulation was assayed by a highly sensitive chemiluminescence method. Kidneys were isolated from DOCA-salt and control rats, and renal perfusion pressure (RPP) and EDNO (by hydrogen peroxide-luminol chemiluminescence) in the perfusate were monitored simultaneously during perfusion of ET-1, ET-3, an ETA receptor antagonist (BQ-123), and an ETB receptor agonist (BQ-3020). In control rats, ET-1 and ET-3 dose-dependently increased both RPP and NO release. Although the vasoconstricting effects of ET-1 were greater, their NO-releasing effects were comparable. The increase in NO release by ETs was inhibited by NG-monomethyl-L-arginine. After 10(-6) mol/L BQ-123 treatment, ET-1 decreased RPP and increased NO release in control kidneys. DOCA-salt rats responded to these agents with much less NO release. BQ-3020 at up to 10(-10) mol/L caused vasodilation (RPP, 10(-11) mol/L, -5.4 +/- 1.7%, P < .01) associated with increased NO release in control kidneys (+9.0 +/- 2.7 fmol.min-1.g-1 kidney wt, P < .01). However, in DOCA-salt kidneys, BQ-3020 caused renal vasoconstriction (RPP, +5.4 +/- 2.4%, P < .01 versus control) and a much smaller NO release (+1.1 +/- 0.4 fmol.min-1.g-1 kidney wt, P < .01 versus control). Northern blot analysis revealed that renal ETB mRNA was significantly decreased in DOCA-salt rat kidneys compared with controls (0.36 +/- 0.13 versus 1.00 +/- 0.23, P < .05).
CONCLUSIONS: These results suggest that ET-1 and ET-3 release EDNO via ETB receptors in renal vessels. ETB-mediated NO release was reduced in DOCA-salt rats, which may modulate renal function and thus blood pressure regulation in DOCA-salt hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7850963     DOI: 10.1161/01.cir.91.4.1229

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

3.  The role of allopurinol on oxidative stress in experimental hyperthyroidism.

Authors:  O Makay; C Yenisey; G Icoz; N Genc Simsek; G Ozgen; M Akyildiz; E Yetkin
Journal:  J Endocrinol Invest       Date:  2009-09       Impact factor: 4.256

4.  ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo.

Authors:  Tiffany L Thai; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-04

Review 5.  The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Authors:  Kirk P Conrad; John M Davison
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

6.  The effect of ozone on blood pressure in DOCA-salt-induced hypertensive rats.

Authors:  Raziye Akcılar; Sezer Akçer; Hasan Şimşek; Aydın Akcılar; Zeynep Bayat; Osman Genç
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.

Authors:  Marc Iglarz; Pauline Steiner; Daniel Wanner; Markus Rey; Patrick Hess; Martine Clozel
Journal:  J Cardiovasc Pharmacol       Date:  2015-10       Impact factor: 3.105

8.  Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb.

Authors:  Paula Dibo; Rodrigo O Marañón; Kiran Chandrashekar; Fernando Mazzuferi; Guillermo B Silva; Luis A Juncos; Luis I Juncos
Journal:  Physiol Rep       Date:  2019-03

9.  Effects of cyclic intermittent hypoxia on ET-1 responsiveness and endothelial dysfunction of pulmonary arteries in rats.

Authors:  Zhuo Wang; Ai-Ying Li; Qiu-Hong Guo; Jian-Ping Zhang; Qi An; Ya-jing Guo; Li Chu; J Woodrow Weiss; En-Sheng Ji
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.